StockData
Century Therapeutics, Inc. logo

Century Therapeutics, Inc. (IPSC) income statement

IPSCNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.38+0.01 (+0.73%)

Close on Nov 18, 2026Market cap $249.88MP/E –Yield –

See a number that looks wrong?